Related Experiment Video
Updated: May 17, 2025

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
Published on: June 6, 2020
Developing an innovation and enterprise framework for translating UK-driven global health research into commercially
Ezekiel Boro1, Charles McLoughlin1, Tom Vaughan2
1Enterprise and Innovation Department, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Abstract:
The UK Higher Education Institution (HEI) sector faces significant challenges in translating early-stage research into commercially viable public health products, particularly in infectious diseases. This gap, often termed the "valley of death," is exacerbated by a fragmented ecosystem and unclear pathways to implementation. The FLIGHT (Framework for Leveraging Innovation in Global Health Technologies) project aims to address these challenges by enhancing the commercialisation of global health research from UK HEIs to drive economic and societal impact. Led by Liverpool School of Tropical Medicine, in partnership with London School of Hygiene and Tropical Medicine, Brighton and Sussex Medical School, and other associated partners, FLIGHT seeks to develop a best practice Innovation and Enterprise Framework (IEF) to support R&D commercialisation. This project will use a mixed-methods approach to assess existing public health R&D assets and the commercialisation knowledge and skills of HEI professionals and Early Career Researchers (ECRs) across partner institutions. Data collection will include literature reviews, surveys, qualitative interviews, and focus group discussions exploring staff and ECR's perceptions and experiences with commercialisation, to identify barriers and opportunities for improvement. Ethical considerations and participant confidentiality are central to the study design. The FLIGHT project aims to bridge critical gaps in the innovation pipeline, fostering a robust ecosystem for translating HEI research into deployable health interventions. This initiative will contribute to strengthening the UK's global health R&D commercialisation capabilities and accelerating the development and deployment of essential public health interventions. Findings will inform policy recommendations and best practice for HEI commercialisation strategies, with implications for both UK and low-and middle-income country (LMIC) contexts.
Related Concept Videos
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
International Nursing Organizations II
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Models of Health Promotion and Illness Prevention I
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...

